# LMH · Implant, Dermal, For Aesthetic Use

_ ·  · Class 3_

**Canonical URL:** https://fda-staging.innolitics.com/productcode/LMH

## Overview

- **Product Code:** LMH
- **Device Name:** Implant, Dermal, For Aesthetic Use
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)
- **Implant:** yes

## Recent Cleared Devices (20 of 56)

Showing 20 most recent of 56 cleared devices.

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P250016](/device/P250016.md) | Belotero® Intense (+) Lidocaine | Merz North America, Inc. | Jul 9, 2026 | APPR |
| [P250021](/device/P250021.md) | saypha® ChiQ™ | Croma-Pharma GmbH | Jun 12, 2026 | APPR |
| [P110033S099](/device/P110033S099.md) | SKINVIVE by JUVEDERM® | Allergan | Jun 11, 2026 | APPR |
| [P250020](/device/P250020.md) | Belotero Volume (+) Lidocaine | Merz North America, Inc. | May 19, 2026 | APPR |
| [P170002S050](/device/P170002S050.md) | RHA Redensity® Eye Lido; RHA Redensity® Eye | Teoxane S.A. | May 12, 2026 | APPR |
| [P050052S162](/device/P050052S162.md) | RADIESSE® Injectable Implant | Merz North America, Inc. | Mar 31, 2026 | APPR |
| [P140029S054](/device/P140029S054.md) | Restylane® Contour | Q-Med AB | Mar 20, 2026 | APPR |
| [P040024S142](/device/P040024S142.md) | Restylane® Lyft with Lidocaine | Q-Med AB | Nov 4, 2025 | APPR |
| [P170002S048](/device/P170002S048.md) | RHA® Dynamic Volume, RHA®4 | Teoxane S.A. | Sep 18, 2025 | APPR |
| [P240008](/device/P240008.md) | saypha® MagIQ™ | Croma-Pharma GmbH | Sep 8, 2025 | APPR |
| [P240022](/device/P240022.md) | EVOLYSSE™ SMOOTH and EVOLYSSE™ FORM | Symatese | Feb 13, 2025 | APPR |
| [P170002S030](/device/P170002S030.md) | RHA®3 dermal filler | Teoxane S.A. | Oct 27, 2023 | APPR |
| [P170002S026](/device/P170002S026.md) | RHA® Redensity Mepi, RHA®2 Mepi, RHA®3 Mepi, RHA®4 Mepi | Teoxane S.A. | Oct 13, 2023 | APPR |
| [P110033S070](/device/P110033S070.md) | Juvéderm® Voluma® XC | Allergan | Oct 6, 2023 | APPR |
| [P090016S050](/device/P090016S050.md) | Belotero Balance (+) Lidocaine | Merz North America, Inc. | Sep 27, 2023 | APPR |
| [P110033S059](/device/P110033S059.md) | Skinvive by Juvéderm | Allergan | May 11, 2023 | APPR |
| [P040024S135](/device/P040024S135.md) | Restylane® Eyelight | Q-Med AB | May 8, 2023 | APPR |
| [P030050S039](/device/P030050S039.md) | Sculptra | Q-Med AB | Apr 25, 2023 | APPR |
| [P110033S065](/device/P110033S065.md) | Juvéderm Volux XC | Allergan | Jul 29, 2022 | APPR |
| [P170002S012](/device/P170002S012.md) | RHA® Redensity™ | Teoxane S.A. | Dec 22, 2021 | APPR |

## Top Applicants

- Q-Med AB — 17 clearances
- Allergan — 13 clearances
- Merz North America, Inc. — 8 clearances
- Teoxane S.A. — 6 clearances
- Croma-Pharma GmbH — 2 clearances

---

**Source:** [https://fda-staging.innolitics.com/productcode/LMH](https://fda-staging.innolitics.com/productcode/LMH)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com